The molecular changes that lead to Fuchs’ endothelial corneal dystrophy (FECD) occur decades before the disease causes blurry vision and other noticeable symptoms in patients, new research by UT Southwestern scientists shows. This insight into this earliest stage of FECD may eventually lead to new ways of screening for and treating the common condition, which affects an estimated 4 percent of U.S. adults over the age of 40.
- Over 80% of Atlantic Rainforest remnants have been impacted by human activity
- ‘Miracle poison’ for novel therapeutics
- Paleontologists discover new insect group after solving 150-year-old mystery
- Tool that more efficiently analyzes ocean color data will become part of NASA program
- Bearded seals are loud – but not loud enough